QUIA PHARMA AB Logo

QUIA PHARMA AB

QUIA | ST

Overview

Corporate Details

ISIN(s):
SE0020678159
LEI:
967600JUP7EI6X9D2Z44
Country:
Sweden
Address:
Virdings Allé 32 B, 754 50 Uppsala
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

QUIA PHARMA AB is a pharmaceutical development company focused on its proprietary and patented drug delivery platform, Uni-Qleaver®. This platform is based on a unique, releasable pegylation technology designed to create improved and patentable versions of both new and existing, approved drugs. The company engages in the research, development, and commercialization of a pipeline of enhanced medicines, aiming to improve the efficacy and properties of pharmaceutical treatments.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for QUIA PHARMA AB. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all QUIA PHARMA AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for QUIA PHARMA AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Spago Nanomedical AB Logo
Develops nanomedicine for precision MRI tumor diagnostics and targeted cancer radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Developing first-in-class macrocyclic drugs for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops and out-licenses preclinical cancer drug programs using fragment-based discovery.
Sweden SPRINT
Stayble Therapeutics AB Logo
Develops an injectable therapy for disc-related spinal disorders as an alternative to surgery.
Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo
Commercializes patented MIC-1 stem cell technology for regenerative medicine.
Poland SCS
STRIX GROUP PLC Logo Isle of Man KETL
SynAct Pharma Logo
Developing oral resolution therapies for inflammatory diseases like rheumatoid arthritis.
Sweden SYNACT
SYNAIRGEN PLC Logo
Develops an inhaled interferon beta therapy for severe viral lung infections.
United Kingdom SNG
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT
Israel TMIS